On November 18, 2025, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a precedential decision in Duke University, Allergan Sales, LLC v. Sandoz Inc., holding claim 30 of U.S. Patent No. 9,579,270...more
12/11/2025
/ Appeals ,
Biotechnology ,
CAFC ,
Disclosure Requirements ,
Intellectual Property Litigation ,
Life Sciences ,
Patent Invalidity ,
Patent Litigation ,
Patent Prosecution ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 112 ,
Written Descriptions
Effective July 8, 2025, the U.S. Patent and Trademark Office (USPTO) expanded the availability of prioritized examination, increasing the limit on the number of requests from 15,000 to 20,000 in a fiscal year. The 20,000...more
7/10/2025
/ Fast Track Process ,
Fees ,
Filing Requirements ,
Final Rules ,
Life Sciences ,
Patent Applications ,
Patent Examinations ,
Patents ,
Pharmaceutical Patents ,
Prioritized Examination ,
Regulatory Agencies ,
Regulatory Reform ,
Request for Continued Examination ,
USPTO